LFB-R603, a Third-Generation Monoclonal Anti-CD20 Antibody, Displays Additive Antitumor Activity with Antileukemic Chemotherapeutic Agents in Mouse Xenograft Models.

Drug Category : Array
Conference Category : Array
Lead Author : Tourais Esteves I, Fournès B, et al.
Published Date : 13/12/2011
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2019/03/ASH2011Poster1660.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top